Falsified medicines in Africa: All talk, no action

The Lancet Global Health

Volumn 2, Issue 9, 2014, Pages e509-e510

  Newton, Paul N ^a,b,c,d   Tabernero, Patricia ^a,b,c   Dwivedi, Prabha ^e   Culzoni, María J ^e,f,g   Monge, María Eugenia ^e,g   Swamidoss, Isabel ^h   Mildenhall, Dallas ⁱ   Green, Michael D ^h   Jähnke, Richard ^j   de Oliveira, Miguel dos Santos ^k   Simao, Julia ^k   White, Nicholas J ^b,c,l   Fernández, Facundo M ^e  

^a MAHOSOT HOSPITAL   (Laos)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^f UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^g Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ GNS SCIENCE   (New Zealand)

^j Global Pharma Health Fund EV   (Germany)

^k Inspecção Geral de Saúde   (Angola)

^l MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; BENFLUMETOL; COCAINE; COUNTERFEIT DRUG; LEVAMISOLE; MEBENDAZOLE; NARCOTIC AGENT; ESSENTIAL DRUG;

AFRICA; AGRANULOCYTOSIS; DRUG ANALYSIS; DRUG PACKAGING; DRUG QUALITY; DRUG RESISTANCE; DRUG WITHDRAWAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LETTER; MALARIA CONTROL; MASS SPECTROMETRY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PUBLIC HEALTH; RAMAN SPECTROMETRY; RISK ASSESSMENT; SEIZURE; VASCULITIS; WORLD HEALTH ORGANIZATION; X RAY POWDER DIFFRACTION; HEALTH; HEALTH CARE DELIVERY; HUMAN; SUPPLY AND DISTRIBUTION;

AFRICA; COUNTERFEIT DRUGS; DRUGS, ESSENTIAL; GLOBAL HEALTH; HEALTH SERVICES ACCESSIBILITY; HUMANS;

EID: 84908394036     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70279-7     Document Type: Letter

References (10)

1. Newton PN, Green MD, Mildenhall DC, et al. Poor quality vital anti-malarials in Africa-an urgent neglected public health priority. Malaria J 2010; 10: 352.
2. Institute of Medicine. Countering the problem of falsifi ed and substandard drugs. Washington, DC: The National Academies Press, 2013.
3. Attaran A, Barry D, Basheer S, et al. How to achieve international action on falsifi ed and substandard medicines: a consensus statement. BMJ 2012; 345: e7381.
4. Faucon B, Murphy C, Whalen J. Africa's malaria battle: fake drug pipeline undercuts progress. Wall Street Journal May 29, 2013. http://online. wsj.com/article/SB100014241278873244740 04578444942841728204.html (accessed April 18, 2014).
5. WHO. Falsifi ed batches of Coartem recently circulating in Cameroon. http://www.who.int/ medicines/publications/drugalerts/ drugalertindex/en/ (accessed April 18, 2014).
6. White NJ, Pongtavornpinyo W, Maude RJ, et al. Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance. Malaria J 2009; 8: 253.
7. Lee KC, Ladizinski B, Federman DG. Complications associated with use of levamisole-contaminated cocaine: an emerging public health challenge. Mayo Clin Proc 2012; 87: 581-86.
8. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med 2005; 2: e100.
9. Taylor N. WHA deal breaks poor quality drugs deadlock. Securing Industry June 3, 2013. http:// www.securingindustry.com/pharmaceuticals/ wha-deal-breaks-poor-quality-drugs-deadlock/ s40/a1746/ (accessed April 18, 2014).
10. WHO Regional Offi ce for Africa. First African Medicines Regulatory Authorities Conference: Final report. Oct 31- Nov 3, 2005; Addis Ababa, Ethiopia. http://apps.who.int/medicinedocs/ en/d/Js17809en/ (accessed April 18, 2014).